Regulation of Gut Inflammation and Th17 Cell Response by Interleukin-21
Open Access
- 1 April 2008
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 134 (4) , 1038-1048.e2
- https://doi.org/10.1053/j.gastro.2008.01.041
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- IL‐21 regulates experimental colitis by modulating the balance between Treg and Th17 cellsEuropean Journal of Immunology, 2007
- Phenotypic and functional features of human Th17 cellsThe Journal of Experimental Medicine, 2007
- Differentiation and function of Th17 T cellsCurrent Opinion in Immunology, 2007
- The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental ColitisJournal of Clinical Immunology, 2007
- Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21Gut, 2006
- Inhibition of Smad7 With a Specific Antisense Oligonucleotide Facilitates TGF-β1–Mediated Suppression of ColitisGastroenterology, 2006
- Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiationNature Reviews Immunology, 2005
- Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- IL-21: a novel IL-2–family lymphokine that modulates B, T, and natural killer cell responsesJournal of Allergy and Clinical Immunology, 2003
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003